Tailorzyme ApSAktiv

CVR 36910674Stiftet 2015

Økonomiske nøgletal

5.155.736 kr.+5,7%
Bruttofortjeneste 2024/25
+4,6%
Gennemsnitlig vækst pr. år 2017/18–2024/25
02 mio.4 mio.6 mio.8 mio.2017/182018/192019/202020/212021/222022/232023/242024/25

Nøgletal

2024/25
Balancens sammensætning
OmsætningsaktiverAnlægsaktiverGæld og hensatte forpligtelserEgenkapital
05 mio.10 mio.2017/182018/192019/202020/212021/222022/232023/242024/25

Udbytte

foreslået
2024/25

Foreslået udbytte for regnskabsåret 200.000 kr. (82% af årets resultat).

Historik
2024/25200.000 kr.
2023/24200.000 kr.
2022/23555.555 kr.
2021/22222.222 kr.
2020/21222.222 kr.

Foreslået udbytte for regnskabsåret fra årsrapportens resultatdisponering (udbetales normalt året efter generalforsamlingen).

Selskabsskat

indkomstår 2024
2024Skattepligtig indkomst 409.560 kr.90.090 kr.
2023Skattepligtig indkomst 1.847.313 kr.Fratrukket underskud 776.660 kr.406.406 kr.
2022Skattepligtig indkomst 0 kr.0 kr.
2021Skattepligtig indkomst 0 kr.0 kr.
2020Skattepligtig indkomst 0 kr.0 kr.
2019Skattepligtig indkomst -776.660 kr.0 kr.
Selskabsskat →

Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk

Regnskabstal2018–2025
2017/182018/192019/202020/212021/222022/232023/242024/25
Balance — aktiver
Likvide beholdninger857.380290.920705.319992.982659.4162.453.9252.527.9413.034.838
Omsætningsaktiver i alt2.370.9231.730.2832.536.1393.695.8135.156.0136.018.5415.362.2625.295.346
Anlægsaktiver i alt33.61320.466132.5881.611.9934.002.9273.725.9523.448.9773.234.422
Aktiver i alt2.404.5361.750.7492.668.7275.307.8069.158.9409.744.4938.811.2398.529.768
Balance — passiver
Kortfristede gældsforpligtelser576.548859.5091.876.5233.325.5624.726.1663.441.7032.999.2452.795.412
Langfristede gældsforpligtelser309.9360779.434240.000321.568467.974326.697266.682
Gældsforpligtelser i alt886.484859.5092.655.9573.565.5625.047.7343.909.6773.325.9423.062.094
Selskabskapital50.00050.00050.00050.00050.00050.00050.00050.000
Overført resultat1.266.650641.240262.770656.352134.3791.691.7011.869.5112.149.095
Årets resultat1.078.206-625.409-378.4701.575.4492.042.9561.813.680167.149243.543
Egenkapital i alt1.516.650891.24012.7701.588.2193.431.1755.044.8554.712.0044.775.547
Resultatopgørelse
Bruttofortjeneste3.775.4951.559.0622.545.8243.553.2056.393.1837.128.0584.876.2475.155.736
Resultat af primær drift1.396.625-769.712-436.4771.834.4192.440.6072.316.774264.635326.855
EBITDA1.409.772-756.565-423.3301.841.7382.440.6072.593.749541.610608.830
Resultat før skat1.387.545-797.172-477.9201.814.8292.416.3462.330.016297.887331.199
Årets resultat1.078.206-625.409-378.4701.575.4492.042.9561.813.680167.149243.543
Personaleomkostninger2.365.7232.315.6272.969.1541.711.4673.952.5764.534.3094.334.6374.546.906
Af- og nedskrivninger13.14713.14713.1477.3190276.975276.975281.975
Andre nøgletal
Ansatte44446765
Udbytte———222.222222.222555.555200.000200.000

En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.

Om virksomheden

Årsrapport 2025

The company's most important activitiesThe company's main activity consists of the manufacture and sale of enzymes and related activities at the discretion of the management. The company focuses on development activities for customers who focus on the processing of residual raw materials from the bio-marine and animal areas. For example, trimmings from fish, chicken, pig and beef that are processed into pure, purified protein hydrolyzate and oil products of high value. Our customers' customers are within pharma, pet food, food & beverages and feed. Vegetable raw materials and insects have the potential to become new investment areas in the coming years. The company has invested in laboratory facilities and, in collaboration with customers, carries out experiments in our laboratory as well as in external pilot and factory plants. In addition, an analysis service is offered. This is a unique offer in the market, which is the driving force in development and essential for the approach of new customers and retention.

The development in activities and economic conditionsThe company's income statement for the year ended 30 June 2025 shows a profit of DKK 243.543, and the balance sheet at 30 June 2025 shows equity of DKK 4.775.547.

Uddrag af ledelsesberetningen i den seneste årsrapport.

Tailorzyme ApS — cvrprofil.dk